Lipocine IncEigentümerstruktur
| Preis (2026-07-24) | 52W Hoch | 52W Tief |
| 2.08 USD | 12,37 USD | 1,81 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 6 USD | 1 | 1 | 0 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 8.244.253 | 1,52 | 1,89 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Lipocine Inc
Mitarbeiter 14
Handelsplatz NASDAQ
Ticker Symbol LPCN
IPO Datum 2013-10-22
Adresse 675 Arapeen Drive, Salt Lake City, UT, United States, 84108
Webseite https://www.lipocine.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Mahesh V. Patel Ph.D. | Co-Founder, President, CEO & Director |
| 2 | Ms. Krista Fogarty | Principal Accounting Officer & Corporate Controller |
| 3 | Dr. Nachiappan Chidambaram Ph.D. | Senior Vice President of Research & Development |
| 4 | Mr. Logan Morse | Vice President of Sales, Marketing & Operations |
| 5 | Dr. Anthony DelConte M. D., M.D. | Chief Medical Director |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Ikarian Capital, LLC | 0,00% | 0,00 Mio. USD |
| 2 | Squadron Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 3 | StemPoint Capital LP | 0,00% | 0,00 Mio. USD |
| 4 | Eversept Partners, LP | 0,00% | 0,00 Mio. USD |
| 5 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 6 | Rosalind Advisors, Inc. | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 8 | AIGH Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 9 | BOOTHBAY FUND MANAGEMENT, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Seven Fleet Capital Management LP | 0,00% | 0,00 Mio. USD |
| 11 | Birchview Capital, LP | 0,00% | 0,00 Mio. USD |
| 12 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 13 | Mink Brook Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 14 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 15 | Exome Asset Management LLC | 0,00% | 0,00 Mio. USD |
| 16 | Diadema Partners LP | 0,00% | 0,00 Mio. USD |
| 17 | J. Goldman & Co LP | 0,00% | 0,00 Mio. USD |
| 18 | Renaissance Technologies Corp | 0,00% | 0,00 Mio. USD |
| 19 | Two Sigma Investments LLC | 0,00% | 0,00 Mio. USD |
| 20 | Vanguard Fiduciary Trust Co | 0,00% | 0,00 Mio. USD |